1. Home
  2. LOAN vs BHST Comparison

LOAN vs BHST Comparison

Compare LOAN & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Manhattan Bridge Capital Inc

LOAN

Manhattan Bridge Capital Inc

HOLD

Current Price

$3.45

Market Cap

47.6M

Sector

Real Estate

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

N/A

Current Price

$1.77

Market Cap

39.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
LOAN
BHST
Founded
1989
2007
Country
United States
Canada
Employees
N/A
89
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
47.6M
39.0M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
LOAN
BHST
Price
$3.45
$1.77
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $10.50
AVG Volume (30 Days)
★ 49.1K
17.2K
Earning Date
10-21-2026
11-12-2026
Dividend Yield
★ 12.61%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.32
N/A
Revenue
★ $8,666,307.00
N/A
Revenue This Year
N/A
$8.44
Revenue Next Year
N/A
$32.53
P/E Ratio
$10.59
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.31
$1.37
52 Week High
$5.22
$12.20

Technical Indicators

Market Signals
Indicator
LOAN
BHST
Relative Strength Index (RSI) 37.51 49.78
Support Level $3.31 $1.40
Resistance Level $4.52 $1.77
Average True Range (ATR) 0.11 0.15
MACD 0.01 0.02
Stochastic Oscillator 21.49 64.51

Price Performance

Historical Comparison
LOAN
BHST

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

Share on Social Networks: